Executive Team

A multidisciplinary team of neuroscience, engineering, and clinical experts committed to advancing innovative solutions for Alzheimer’s and other neurodegenerative diseases.

CEO & Co-Founder

Former Intellectual Property head of Gencell and experienced French and European patent attorney with over 25 years of experience in intellectual property and biotech innovations.

CSO & Co-Founder

Neuroscientist and biotech innovator with deep expertise in neurodegenerative diseases, optical imaging, and translational drug discovery.

CTO & Co-Founder

Highly experienced radiofrequency and microwave engineer with over 30 years of experience in R&D and telecommunication innovations.

Over 10 years of experience in the deployment and strategy of complex international clinical trials, supporting biotech and pharma companies.

Advisory Board

Our Clinical & Scientific Advisory Board (CSAB) brings together leading experts in Alzheimer’s and other neurodegenerative diseases. The Board provides strategic clinical and scientific guidance to advance Neurocia’s mission of improving the lives of those affected by these conditions. Their insights help shape our leadership in non-invasive neuromodulation therapies and drive the development of impactful, patient-centered innovations.

Our Resources

Latest Posts

External Research & Innovations
Radiofrequency Neuromodulation

Non-invasive Pulsed Radiofrequency for Chronic Migraine

Non-invasive pulsed radiofrequency therapy is safe and effective for reducing pain intensity and frequency in chronic migraine, comparable to greater occipital nerve block.
January 2024
Photobiomodulation

Photobiomodulation for Neurodegenerative Diseases

This recent review highlights the potential of photobiomodulation in mitigating symptoms and progression in neurodegenerative diseases like Alzheimer’s and Parkinson’s, synthesizing evidence from animal and clinical studies.
June 2024
Gamma Entrainment

The Role of Gamma Oscillations in Central Nervous System Diseases

This review discusses the role of gamma oscillations in regulating brain plasticity, neuroinflammation, and amyloid processing, advocating gamma entrainment as a promising non-invasive neuromodulation tool.
April 2022